Rat And Mouse Model Industry Overview
The global rat and mouse model market size was valued at USD 1.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.5% from 2021 to 2028.
The growth of this market is majorly driven by the increasing demand for genetically modified models to help researchers identify and validate therapeutic targets. Additionally, increasing expenditures in RD activities in the pharmaceutical and biotechnology sector is likely to fuel market growth. A rise in demand for humanized ACE2 (hACE2) mouse models to study the pathogenesis of SARS-CoV-2 propels the market growth.
Gather more insights about the market drivers, restrains and growth of the Global Rat And Mouse Model Market
Several key players are focused to produce models that can aid in COVID-19 research. For instance, Applied StemCell, Inc.; a U.S.-based biotechnology company has used its TARGAT knockin technology to develop hACE2 models to assess the efficacy of vaccines, antiviral drugs, and evaluate the severity of COVID-19 pathogenesis.
The COVID-19 pandemic has created abundant opportunities for the market players. In September 2021, GemPharmatech Co., Ltd. (GPT) participated in the Biologics UK Oxford Global Conference to represent its humanized mouse models to assist the COVID-19 preclinical development.
The growth of personalized medicine boosts the demand for humanized rat and mouse models across the globe. Charles River Laboratories offers custom rare disease and microbiome models that support personalized therapy drug trials. The growing need for primary tissue/cells and human-like animal models propel the demand for customized models to assess safety, efficacy, and target validation in cellular therapies.
Browse through Grand View Research's Biotechnology Industry Research Reports.
- Biotechnology Pharmaceutical Services Outsourcing Market - The global biotechnology and pharmaceutical services outsourcing market size was valued at USD 66.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.5% from 2022 to 2030. The COVID-19 pandemic has had a considerable impact on the biotechnology and pharmaceutical services outsourcing industry. Restrictions on movement and stay-at-home orders are helping reduce the spread of COVID-19.
- Biotechnology Market - The global biotechnology market size was estimated at USD 1,023.92 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 13.9% from 2022 to 2030. The market is driven by strong government support through initiatives aimed at modernization of regulatory framework, improvements in approval processes reimbursement policies, as well as standardization of clinical studies.
Rat And Mouse Model Market Segmentation
Grand View Research has segmented the global rat and mouse model market based on type, technology, service, application, end-use, and region:
Rat And Mouse Model Type Outlook (Revenue, USD Million, 2018 - 2028)
- Knockout
- Knock-in
- Outbred
- Inbred
- Others
Rat And Mouse Model Technology Outlook (Revenue, USD Million, 2018 - 2028)
- Nuclear transferase
- Microinjection
- Embryonic stem cells
- CRISPR/Cas9
- Other Technologies
Rat And Mouse Model Service Outlook (Revenue, USD Million, 2018 - 2028)
- Cryopreservation
- Breeding
- Rederivation
- Genetic testing
- Quarantine depending
- Others
Rat And Mouse Model Application Outlook (Revenue, USD Million, 2018 - 2028)
- Cardiovascular diseases
- Genetic diseases
- Cancer
- Infectious diseases
- COVID-19
- Others
- Transplantation
- Toxicology studies
- Others
Rat And Mouse Model End-use Outlook (Revenue, USD Million, 2018 - 2028)
- Pharmaceutical biotechnology companies
- Academic and research facilities
- Contract research manufacturing organizations
Rat And Mouse Model Regional Outlook (Revenue, USD Million, 2018 - 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
Market Share Insights
- September 2021: A team of researchers from the Universitat Autònoma de Barcelona (UAB); Spain generated a rat model which could recapitulate the disabling alterations observed in patients with Morquio A disease or Mucopolysaccharidosis type IVA.
- January 2021: According to a research publication, rat and mouse models comprise 99.3% of the mammals used in 16 large American institutions. Therefore, a high utilization rate of these models in the region propels revenue growth.
- February 2020: Taconic Biosciences began the production of mouse models with the humanized immune system in Europe. This expanded the company’s manufacturing capacity as well as its customer base in Europe.
Key Companies profiled:
Some prominent players in the global rat and mouse model market include
- Charles River Laboratories International, Inc.
- The Jackson Laboratory
- Laboratory Corporation of America Holdings (Covance)
- Perkin Elmer (Horizon Discovery Group plc)
- genOway
- Envigo
- JANVIER LABS
- Taconic Biosciences, Inc.
- Biomedical Research Models (Biomere)
- Transpogen Biopharmaceutical, Inc.
Order a free sample PDF of the Rat And Mouse Model Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
